VEGF 165 Protéine
-
- Antigène
- VEGF 165
- Type de proteíne
- Recombinant
-
Origine
- Humain
-
Source
- Escherichia coli (E. coli)
- Application
- SDS-PAGE (SDS)
- Séquence
- MAPMAEGGGQ NHHEVVKFMD VYQRSYCHPI ETLVDIFQEY PDEIEYIFKP SCVPLMRCGG CCNDEGLECV PTEESNITMQ IMRIKPHQGQ HIGEMSFLQH NKCECRPKKD RARQENPCGP CSERRKHLFV QDPQTCKCSC KNTDSRCKAR QLELNERTCR CDKPRR
- Attributs du produit
-
Purified recombinant Human VEGF165 Protein
Expression System: E.coli - Pureté
- > 90 % pure
-
-
- Indications d'application
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 500 µg/mL
- Buffer
- Supplied in liquid form in 20 mM Tris-HCl buffer, pH 8.0, containing 0 mM EDTA, 0.0 mM PMSF, 0 mM DTT.
- Agent conservateur
- Dithiothreitol (DTT)
- Précaution d'utilisation
- This product contains Dithiothreitol: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
- Stock
- 4 °C/-20 °C
- Stockage commentaire
- Store at 4 °C for short term storage. Aliquot and store at -20 °C for long term storage.
-
- Antigène
- VEGF 165
- Autre désignation
- VEGF165
- Sujet
-
VEGF165 is a signal protein produced by cells that stimulates vasculogenesis and angiogenesis. It is part of the system that restores the oxygen supply to tissues when blood circulation is inadequate. Serum concentration of VEGF is high in Bronchial Asthma and low in Diabetes Mellitus. VEGF's normal function is to create new blood vessels during embryonic development, new blood vessels after injury, muscle following exercise, and new vessels (collateral circulation) to bypass blocked vessels.
Alternative Names: VEGF protein, VEGF 165 protein, MVCD1 protein, VEGF-165 protein, Vascular endothelial growth factor A protein, VPF protein, VEGF165, VEGF-165, VEGF 165 - Poids moléculaire
- 19.3 kDa
-